Skip to main content

Continuous glucose monitoring (CGM)

28
May 2025

Updates in coverage recommendations for CGM devices in type 2 diabetes in Sweden

On May 8, 2025, the Medical Technologies Product (MTP) Council revised its recommendations on continuous glucose monitoring (CGM) for patients with type 2 diabetes (T2D), initially issued in 2022 under the Orderly Introduction of Medical Technologies framework. The updated recommendations now allow the use of other CGM devices considered equivalent to FreeStyle Libre and FreeStyle Libre 2, which were the only recommended products in 2022. Simultaneously, the MTP Council initiated a reassessment of CGM devices for T2D and tasked the Dental and Pharmaceutical Benefits Agency (TLV) to carry out a new health economic evaluation.
05
May 2025

Recommendations about add-on reimbursement for medical devices in France in April 2025

The French National Authority for Health (HAS) released new recommendations regarding add-on the registration of reimbursement for medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the April 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Eleven favorable opinions were published concerning the registration of new devices or modifying conditions/indications for existing ones in the LPPR List. The recommendations relate to devices in the fields of endocrine, e-health, neuromodulation, peripheral vascular, and medical aids.
04
Jul 2024

Recommendations about add-on reimbursement for medical devices in France in June 2024

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in June 2024. Twelve recommendations were published concerning the registration of medical devices or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular and endocrine devices, as well as medical aids.
22
Mar 2024

Ongoing HTAs in Norway in March 2024

In March 2024, several method assessments were initiated as a part of a framework for the managed introduction of innovations "New Methods" for cardiovascular, endocrine, gastrointestinal, men’s health, neurology and neurosurgery, neuromodulation, obstetrics and gynecology, robotic surgery, and some other fields.
13
Mar 2024

Ongoing HTAs by SESCS in Spain in March 2024

In March 2024, the Evaluation and Planning Service of the Canary Islands Health Service (SESCS) is working on several HTAs, including evaluations in the cardiovascular, endocrine, neurology and neurosurgery, orthopedics, surgical procedures, and some other fields.
01
Mar 2024

Recommendations about add-on reimbursement for medical devices in France in February 2024

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in February 2024. Fourteen recommendations were published concerning the registration of medical devices or modification of registration conditions with the extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular, neurovascular, neuromodulation, endocrine, and endoscopy devices, as well as medical aids.
19
Feb 2024

Five-year implementation strategy for Hybrid closed loop technologies in England

On January 22, 2024, NHS England published a 5-year implementation strategy for Hybrid closed loop (HCL) technologies following the NICE technology appraisal (TA943) publication. As a rule, commissioners and providers must implement TA recommendations within three months. However, an agreed five-year implementation will allow NHS to build specialist competencies and cost-effective procurement. NHS England will fund integrated care boards to reimburse the use of HCL systems
08
Nov 2023

Recommendations about add-on reimbursement for medical devices in France in October 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in October 2023. Twelve recommendations were published in relation to the registration of medical devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular, e-health, endocrine, gastrointestinal, neurology and neurosurgery, neuromodulation, and orthopedic devices, as well as medical aids.
30
Aug 2023

Ongoing HTAs by SESCS in Spain in August 2023

In August 2023, the Evaluation and Planning Service of the Canary Islands Health Service (SESCS) is working on several HTAs, including evaluations in the cardiovascular, endocrine, neurology and neurosurgery, orthopedics, surgical procedures, and some other fields.